Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite

Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases

By Parajuli Nirmal   Ramprasath Tharmarajan   Patel Vaibhav B.   Wang Wang   Putko Brendan   Mori Jun   Oudit Gavin Y.  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 7, 2014-01 ,pp. : 558-565

NRC Research Press

Access to resources Recommend Favorite

Renin-angiotensin System Blockade at the Level of the Angiotensin Converting Enzyme or the Angiotensin Type-1 Receptor: Similarities and Differences

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-01 ,pp. : 473-481

Bentham Science Publishers

Access to resources Recommend Favorite

Hematocrit-lowering Effect Following Inactivation of Renin-Angiotensin System with Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-02 ,pp. : 483-486

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-05 ,pp. : 603-609

Bentham Science Publishers

Access to resources Recommend Favorite